INCY · Incyte Corp

$117.25 +0.60 (+0.51%) At close · Jul 17

Market Cap

$23.42B

199,782,155

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William Meury	CEO	$647,260	—	$27,509,657	$2,573,998	$1,300,000	$55,037	$32,085,952
Mohamed Issa	VP of Commercial Operations	$690,411	$1,000,000	$7,870,118	$450,983	$533,610	$47,660	$10,592,782
Pablo Cagnoni	President and Head of R&D	$966,516	—	$4,952,378	$1,815,159	$1,007,027	$97,881	$8,838,961
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$835,067	—	$3,466,675	$1,270,592	$696,054	$35,784	$6,304,172
Christiana Stamoulis	CFO	$520,839	—	$3,136,468	$1,149,588	—	$129,655	$4,936,550
Thomas Tray	Chief Accounting Officer	$358,189	—	$305,897	$154,623	$149,423	$22,236	$990,368

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pablo Cagnoni	President and Head of R&D	$933,344	—	$4,463,962	$1,404,291	$1,042,470	$60,232	$7,904,299
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$806,406	—	$3,124,735	$1,295,829	$720,553	$32,305	$5,979,828
Christiana Stamoulis	CFO	$712,242	—	$2,827,129	$1,172,420	$636,414	$49,552	$5,397,757

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pablo Cagnoni	President and Head of R&D	$517,808	$737,362	$14,089,823	$450,377	$735,750	$39,183	$16,570,303
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$775,580	—	$2,925,757	$1,386,951	$508,549	$31,256	$5,628,093
Christiana Stamoulis	CFO	$684,288	—	$2,647,095	$1,254,863	$449,166	$49,073	$5,084,485

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christiana Stamoulis	CFO	$585,468	—	$1,743,359	$1,421,498	$375,321	$28,604	$4,154,250
Barry Flannelly	President, U.S. Commercial	$480,542	—	$2,342,694	$940,557	$308,057	$45,034	$4,116,884
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$576,321	—	$1,418,393	$940,557	$369,457	$22,022	$3,326,750
Vijay Iyengar	Executive Vice President, Global Strategy and Corporate Development	$552,278	—	$1,418,393	$940,557	$353,299	$40,323	$3,304,850

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$549,812	—	$4,868,505	$1,235,249	$363,825	$24,093	$7,041,484
Wenqing Yao	Executive Vice President, Head of Discovery Chemistry	$485,405	—	$4,868,505	$1,235,249	$321,206	$41,195	$6,951,560
Barry Flannelly	President, U.S. Commercial	$458,438	—	$1,149,505	$3,490,293	$303,361	$41,345	$5,442,942
Christiana Stamoulis	CFO	$497,096	$280,000	$824,960	$2,474,685	$369,600	$49,327	$4,495,668

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$522,123	—	$3,733,824	$2,119,070	$212,625	$23,874	$6,611,516
Wenqing Yao	Executive Vice President, Head of Discovery Chemistry	$462,723	—	$3,733,824	$2,119,070	$187,718	$36,716	$6,540,051

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Steven H. Stein	Executive Vice President, Chief Medical Officer and Head of Late-stage Development	$473,070	$100,000	$451,372	$2,688,504	$362,188	$24,121	$4,099,255
Wenqing Yao	Executive Vice President, Head of Discovery Chemistry	$448,798	—	$451,372	$2,688,504	$343,125	$41,374	$3,973,173

Key facts CIK 879169 CUSIP 45337C102 13F (30d) 132 filings 111 filers Visit website